Recently, nonisotopic (often automated) immunoassays for measuring serum free thyroxin (FT 4 ) have become available. Though more costly than radioimmunoassays, they are considerably more convenient. We studied the influence of endogenous albumin and thyroxin-binding globulin concentration on five automated, nonisotopic methods of measuring FT 4 [Enzymun on ES300 (one-step), Stratus I and II (essentially two-step), Delfia (two-step), and IM x (two-step)] in a mixed patient population. We observed that they (a) are influenced very little by endogenous serum binding proteins and (b) seem to have sufficient within-run precision to justify performing single measurements on patients' specimens.
In recent years, determining serum free thyroxin (FT4) concentration has become commonplace in clinical laboratories. This was made possible originally by the development of radioimmunoassay (RIA) kits, which were considerably more convenient and less expensive than equilibrium dialysis. At present, most RIAs use a procedure in which patient's serum, anti-Tr, and labelled T 4 (or an analogue of T 4 ) are mixed and incubated all in one step. A few methods use a two-step procedure in which only the patient's serum and anti-T4 are mixed during the first incubation. Then, after removal of the serum, labelled T 4 is added for a second incubation in order to label the unoccupied anti-T4 binding sites. While two-step methods are less convenient, they are also considerably less affected by variations in the patient's thyroxin-binding globulin (TBG) or albumin concentrations 1-3 presumably because the serum is not in contact with the labelled hormone in the two-step procedure.
More recently, nonisotopic, automated immunoassays have become available that are even more convenient, though more costly, than the RIA kits. We examine the effect of endogenous albumin and TBG concentrations on Correspondence: Dr MH Zweig. five of these tests: one one-step, two essentially two-step and two two-step procedures. For comparison, we used a two-step RIA that has been extensively studied in our previous investigations of possible transport-protein dependence.i-' Because the new automated immunoassays are designed for running singly, we derived precision profiles to determine whether the variability was appropriately smaller than with manual radioassays.
MATERIALS AND METHODS

Samples
To study binding-protein effects, we selected serum samples on the basis of their albumin and TBG concentrations. For method comparisons, we chose samples with values spread over the usual range of the assays. The samples were taken from those received routinely by the NIH Clinical Chemistry Service, Clinical Pathology Department. The study thus included samples from both inand outpatients who suffered from non-thyroidal or thyroidal illnesses or were healthy at the time of blood sampling.
Free thyroxin methods Five nonisotopic, automated immunoassay methods (including two versions of the essentially Zweig two-step assay) and one manual, two-step RIA (in routine use in the laboratory) were examined. Manufacturer's expected euthyroid intervals appear in parentheses: 
Other methods
Serum albumin concentrations were measured on an Hitachi 736, using the bromo-crestol green dyebinding method. Serum TBG was measured by an immunoradiometric assay (Immunophase TBG, Ciba Coming Diagnostics Corp., Medfield, MA, USA). Within-run precision profiles were generated by assaying selected patient serum samples in duplicate, over several days. Patients' serum samples were preferred over quality-control serum to reflect possible matrix differences in the coefficient of variation (CV) obtained for precision. A recent study with Stratus FT4 indeed suggests that the matrix differences between patients' serum and quality-control serum might be significant in relation to the diffusion of materials through the glass-fibre matrix."
Statistical analysis
We used simple linear regression for analysis of relationships between serum FT4 and binding proteins. We excluded three outlying points from the analyses (Clinical Assays versus TBG) by omitting data points that generated residuals greater than 4 Sy.x.S We used Deming debiased regression analysis, assuming equal error in the x and the y variables, for comparison between methods."
RESULTS
Correlation of IT4 with TUG concentration
Both positive and negative correlations were observed, but only the ES300, Stratus I, Delfia, and Clinical Assays methods had slopes significantly different from zero (Fig. 1) . Note that the IMx assay has a very small positive slope, which was not statistically significant. Clinical Assays has a statistically significant negative correlation (slope = -0'15), based on 182 observations. This compares to our previous report of a positive correlation (slope = o· 168), which was not statistically significant. 2, 3 The ES300 assay, a one-step procedure, behaved similarly, as did the newer version of the two essentially two-step procedures, Stratus II. The largest slope observed was -O·452 for the Stratus I. This represents a change of -O·452 pmol/L FT4 per mg/L of TBG. Expected values for euthyroid patients using Stratus I are approximately 11· 6-27 pmollL. A difference of 10 mg/L of THO would correspond to a change of -4· 52 pmollL of IT4' or 29% of the width of the euthyroid range. However, if three points ( Fig. 1) with FT4 concentrations greater than 60 pmollL (but with residuals of less than 4 Sy.x) are omitted, the slope for Stratus I decreases from -0'45 to -0,23. For Clinical Assays, a wellestablished two-step RIA, a change of 10 mg/L of THO corresponds to 1· 5 pmollL of FT 4' which is about 91110 of the euthyroid range. Stratus II, Delfia, and particularly IMx, showed even smaller effects.
Correlation of FT 4 with albumin concentration
The slopes ranged from 0'0002 (ES300) to 0'12 (Stratus II and Delfia), most being positive ( Fig. Nonisotopic Free Thyroxin Assays 553 2). For Delfia, a difference of 10 giL of albumin corresponds to a change of 1· 2 pmolll of IT4, or about 11070 of the euthyroid range. The slope observed for Clinical Assays, 0'0736, was significantly different from zero; previously, we observed a slope of O' 117 for this method, which was not significantly different from zero. I Differences in factors such as drugs, fatty acids, and other endogenous substances might be responsible for the slightly different slopes obtained in the two studies.
Correlation among FT 4 assays
Each method was compared to Clinical Assays. Deming debiased regressions appear in Table 1 . Interestingly, a comparatively weak correlation between Clinical Assays and De1fia, another twostep assay, occurred. Also noteworthy is that, although the manufacturers' reference intervals are virtually identical, a proportional bias of as much as 201110 was seen between Irnx and Clinical Assays.
Precision studies
RIAs have normally been run in duplicate, with the mean of the two taken as the estimate of true concentration. The newer nonisotopic, automated immunoassay systems such as we examined here are designed to use single determinations to estimate true concentration. In order that the confidence of estimates based on single determinations be equivalent to that of duplicate determinations, the within-run CV of the automated systems must be no more than O' 707 times the CV of the system using duplicates. We found that, indeed, the within-run CVs (calculated from duplicates) of the automated ES300 and IMx were less than O' 707 times that of the traditional RIA, Clinical Assays, at all points examined (Fig. 3) .
DISCUSSION
All of the automated nonisotopic methods we examined had only minor associations with binding-protein concentrations in a mixed patient population compared to our previous findings Stratus I nor II is a two-step method in the conventional sense, both the serum FT4 that is not bound to the membrane and the other serum components (including albumin and TBG) are 'washed out' to the edge of the glass-fibre membrane by the solvent front of the enzymelabelled T 4 as it is added. Thus, although there is 'contact' between the serum binding proteins and the labelled T4' it appears to be limited and, in general, does not affect the label's binding to the unoccupied anti-T, sites. A recent report, however, suggested that in patients with familial dysalbuminemic hyperthyroxinemia the FT 4 concentration from Stratus should be considered with caution because it is likely an overestimate. IO On the other hand, T 4 autoantibodies, II varying serum albumin concentrations.lv'? and third-trimester pregnancy (a time when alteration in thyroid hormone transport proteins is known to occur)" did not affect results for FT4 with the Stratus method.
Generally, good correlations (either by regression analysis or diagnostic classification of patients) were found between the new nonisotopic FT 4 assays and 'reference methods', such as conventional two-step RIAs and/or equilibrium dialysis. 8 -12 Our findings for intermethod correlations are consistent with these earlier reports. Our observation for the slope of Clinical Assays versus IMx suggests, however, discrepancy in standardization.
Within-run precision is an important issue because these newer automated nonisotopic assays are economically more feasible if run singly than doubly, as with conventional manual RIAs. The data shown in Fig. 3 indicate that the two automated systems we examined are precise enough to provide results equivalent to those derived from Clinical Assays, a conventional RIA run in duplicate. That is, the CVs for the automated systems were less than 0'707 times the CVs of the RIA.
In conclusion, newer automated nonisotopic methods for estimating FT 4, based on our limited data, appear to provide results that are relatively free of influence from albumin and TBG and have acceptable precision for single determinations.
. in which the sequential procedure assures no contact between serum binding proteins and label. No correlation was found between serum albumin and FT 4 measured by Delfia in a previous work." We found no published data for the performance of the IM x FT 4 method in the presence of changing binding-protein concentrations.
The same observation was, surprisingly, true even for the ES300, a one-step assay, in which the label is thyroxin conjugated to horseradish peroxidase. Our findings are consistent with the manufacturer's claim stating that the conjugate 'does not bind significantly to TBG or TBPA', and that 'binding of the conjugate to anti-T4 antibody is negligibly influenced by the presence of albumin'. 8 Likewise, other researchers detected little or no effect of changing serum protein concentrations, distribution and/or affinity (e.g., in pregnant patients, patients with severe nonthyroidal illness, or familial dysalbuminemic hyperthyroxinemia) on the FT 4 measured by the ES300 Enzymun.?
This was also true, for the two versions of the essentially two-step method (Stratus I and II). Both used identical reagents but were run on different instruments. Stratus I requires a dilution step done separately from the instrument, whereas Stratus II performs the dilution on the instrument and has more advanced software. While neither 
